





































































Diseases Main aggregate component
Alzheimer’s disease Amyloid β peptides, tau protein
Spongiform encephalopathies Prion
Parkinson’s disease α-Synuclein
Primary systemic amyloidosis Ig light chain
Secondary systemic amyloidosis Serum amyloid A
Front-temporal dementias Tau
Senile systemic amyloidosis Transthyretin
Familial amyloid polyneuropathy I Transthyretin
Hereditary cerebral amyloid angiopathy Cystatin C
Haemodialysis-related amyloidosis β2-Microglobulin
Familial amyloid polyneuropathy III Apolipoprotein AI
Finnish hereditary systemic amyloidosis Gelsolin
Type II diabetes Amylin
Medullary carcinoma of the thyroid Calcitonin
Atrial amyloidosis Atrial natriuretic factor
Hereditary non-neuropathic systemic amyloidosis Lysozyme
Injection-localised amyloidosis Insulin
Hereditary renal amyloidosis Fibrinogen α-A-chain, transthyretin, apolipoprotein AI, apolipoprotein AII,lysozyme, gelsolin, cystatin C
Amyotrophic lateral sclerosis Superoxide dismutase I
Huntington’s disease Huntingtin
Spinal and bulbar muscular atrophy Androgen receptor
Spinocerebellar ataxias Ataxins
Spinocerebellar ataxia 17 TATA box-binding protein
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